(Q52888397)

English

Residual disease detected by multidimensional flow cytometry shows prognostic significance in childhood acute myeloid leukemia with intermediate cytogenetics and negative FLT3-ITD: a report from the Tokyo Children's Cancer Study Group.

scientific article published on 18 January 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Residual disease detected by multidimensional flow cytometry shows prognostic significance in childhood acute myeloid leukemia with intermediate cytogenetics and negative FLT3-ITD: a report from the Tokyo Children's Cancer Study Group (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

based on heuristic

inferred from title

childhood acute myeloid leukemia

1 reference

based on heuristic

inferred from title

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

20

object named as

Atsushi Manabe

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Dai Keino

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Akitoshi Kinoshita

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Daisuke Tomizawa

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Hiroyuki Takahashi

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Kohmei Ida

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Hidemitsu Kurosawa

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Kazutoshi Koike

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Setsuo Ota

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Noriyuki Iwasaki

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Junya Fujimura

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Yuki Yuza

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Chikako Kiyotani

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Shohei Yamamoto

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Takahiro Ueda

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Shinji Mochizuki

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Keiichi Isoyama

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Ryoji Hanada

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Akio Tawa

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Yoichi Toguchi

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Akira Ohara

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

18 January 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

International Journal of Hematology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

103

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

416-422

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

https://scigraph.springernature.com/pub.10.1007/s12185-016-1937-y

0 references

Clinical implications of FLT3 mutations in pediatric AML.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1937-Y

21 January 2018

Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1937-Y

21 January 2018

Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1937-Y

21 January 2018

Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1937-Y

21 January 2018

Biology, risk stratification, and therapy of pediatric acute leukemias: an update

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1937-Y

21 January 2018

Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1937-Y

21 January 2018

Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1937-Y

21 January 2018

Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1937-Y

21 January 2018

Clinical significance of minimal residual disease detected by multidimensional flow cytometry: serial monitoring after allogeneic stem cell transplantation for acute leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1937-Y

21 January 2018

Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1937-Y

21 January 2018

Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1937-Y

21 January 2018

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1937-Y

21 January 2018

Comparative analysis of different approaches to measure treatment response in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1937-Y

21 January 2018

Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for "prime time"?

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1937-Y

21 January 2018

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1937-Y

21 January 2018

Review of the relevance of aberrant antigen expression by flow cytometry in myeloid neoplasms

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1937-Y

21 January 2018

Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1937-Y

21 January 2018

Relevance of leukemic stem cells in acute myeloid leukemia: heterogeneity and influence on disease monitoring, prognosis and treatment design

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1937-Y

21 January 2018

Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1937-Y

21 January 2018

Flow cytometry in myelodysplastic syndromes: report from a working conference

1 reference

https://pubmed.ncbi.nlm.nih.gov/26781613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Status of minimal residual disease testing in childhood haematological malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/26781613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26781613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26781613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate

1 reference

https://pubmed.ncbi.nlm.nih.gov/26781613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD45 gating for routine flow cytometric analysis of human bone marrow specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/26781613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Excess treatment reduction including anthracyclines results in higher incidence of relapse in core binding factor acute myeloid leukemia in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/26781613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26781613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

1 reference

https://pubmed.ncbi.nlm.nih.gov/26781613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol

1 reference

https://pubmed.ncbi.nlm.nih.gov/26781613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821

1 reference

https://pubmed.ncbi.nlm.nih.gov/26781613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26781613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12185-016-1937-Y

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26781613%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52888397&oldid=1823450054"